Adriaan Aarts
Chief Financial Officer
Adriaan (born in 1965) studied Economics at Tilburg University and began his career in banking. After spending two years at…
Rob Collin, PhD
Chief Executive Officer, Founder, Inventor RNA Therapy
“Due to their high specificity, antisense oligonucleotides hold great promise to correct RNA defects underlying many inherited diseases”
Erwin van Wijk, PhD
Chief Scientific Officer
"Being able to save vision will be a life-changing event for people with a blinding disorder"
Melita Kaltak, PhD
Chief Operating Officer
"I'm committed to helping develop solutions for individuals with vision disorders. My goal is to advance antisense oligonucleotides from research to clinical trials, making a difference in the lives of the community affected by Stargardt disease and Usher syndrome."